Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review

Introduction In the context of the opioid crisis in North America, the benefits of evidence-based opioid agonist treatments such as buprenorphine/naloxone have not been optimised due to low uptake. Numerous factors contribute to the underuse of buprenorphine, and theory-informed approaches to identi...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Kimberly Corace, Sharon E Straus, Carol Strike, Triti Khorasheh, Sheena Taha, Heather Manson, Ahmed M Bayoumi, Elisabeth Marks, Beata Pach, Keith Ahamad, Erin Grennell, Melissa Holowaty
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 2019-12-01
Serier:	BMJ Open
Online adgang:	https://bmjopen.bmj.com/content/9/12/e032285.full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!